4.7 Article

ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers

Journal

CLINICAL CANCER RESEARCH
Volume 24, Issue 16, Pages 3917-3927

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-17-3775

Keywords

-

Categories

Funding

  1. Medical Research Council, UK [G1001692]
  2. Northern Ireland Biobank [NIB13-001]
  3. HSC Research and Development Division of the Public Health Agency in Northern Ireland
  4. Friends of the Cancer Centre
  5. FMHLS, Genomics Core Technology Unit, Queen's University Belfast
  6. MRC [G0700754, G1001692] Funding Source: UKRI

Ask authors/readers for more resources

Purpose: To investigate the regulation of epithelial-to-mesenchymal transition (EMT) in head and neck squamous cell carcinoma (HNSCC) and its importance in tumor invasion. Experimental Design: We use a three-dimensional invasive organotypic raft culture model of human foreskin keratinocytes expressing the E6/E7 genes of the human papilloma virus-16, coupled with bioinformatic and IHC analysis of patient samples to investigate the role played by EMT in invasion and identify effectors and upstream regulatory pathways. Results: We identify SNAI2 (Slug) as a critical effector of EMT-activated downstream of TP63 overexpression in HNSCC. Splice-form-specific depletion and rescue experiments further identify the Delta Np63 gamma isoform as both necessary and sufficient to activate the SRC signaling axis and SNAI2-mediated EMT and invasion. Moreover, elevated SRC levels are associated with poor outcome in patients with HNSCC in The Cancer Genome Atlas dataset. Importantly, the effects on EMT and invasions and SNAI2 expression can be reversed by genetic or pharmacologic inhibition of SRC. Conclusions: Overexpression of Delta Np63 gamma modulates cell invasion by inducing targetable SRC-Slug-evoked EMT in HNSCC, which can be reversed by inhibitors of the SRC signaling. (C) 2018 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data

Baharak Ahmaderaghi, Raheleh Amirkhah, James Jackson, Tamsin R. M. Lannagan, Kathryn Gilroy, Sudhir B. Malla, Keara L. Redmond, Gerard Quinn, Simon S. McDade, Tim Maughan, Simon Leedham, Andrew S. D. Campbell, Owen J. Sansom, Mark Lawler, Philip D. Dunne

Summary: We have developed an open source data analysis platform called MouSR, which allows 'wet-lab' users to easily analyze transcriptional data without requiring programming skills. This platform provides a user-friendly interface and a suite of molecular characterization options for rapid transcriptomic analysis, addressing a major bottleneck in biological discovery.

DISEASE MODELS & MECHANISMS (2022)

Article Oncology

Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists

Vera Grinkevitch, Mark Wappett, Nyree Crawford, Stacey Price, Andrea Lees, Christopher McCann, Katherine McAllister, Jochen Prehn, Jamie Young, Jess Bateson, Lewis Gallagher, Magali Michaut, Vivek Iyer, Aikaterini Chatzipli, Syd Barthorpe, Daniel Ciznadija, Ido Sloma, Amy Wesa, David A. Tice, Lodewyk Wessels, Mathew Garnett, Daniel B. Longley, Ultan McDermott, Simon S. McDade

Summary: Second-generation TRAIL-R2 agonists face two major clinical challenges: lack of predictive biomarkers and development of resistance. This study identifies caspase-8:FLIP(L) and caspase-8:MCL-1 ratios as potential predictive biomarkers for second-generation TRAIL-R2 agonists, and loss of key effectors like FADD and caspase-8 as likely drivers of clinical resistance in solid tumors.

MOLECULAR CANCER THERAPEUTICS (2022)

Article Pathology

Identification of a prognostic signature in colorectal cancer using combinatorial algorithm-driven analysis

Abdo Alnabulsi, Tiehui Wang, Wei Pang, Marius Ionescu, Stephanie G. Craig, Matthew P. Humphries, Kris McCombe, Manuel Salto Tellez, Ayham Alnabulsi, Graeme Murray

Summary: A study developed an effective methodology to identify optimal biomarker combinations for the prognosis of colorectal carcinoma. Six biomarkers were identified as the best combination in terms of prognostic power, and it was significantly associated with overall survival and independent of other clinicopathological parameters. The study also demonstrated the potential of this methodology for biomarker discovery in various biological and clinical studies.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2022)

Article Biochemical Research Methods

classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes

Gerard P. Quinn, Tamas Sessler, Baharak Ahmaderaghi, Shauna Lambe, Harper VanSteenhouse, Mark Lawler, Mark Wappett, Bruce Seligmann, Daniel B. Longley, Simon S. McDade

Summary: classifieR is an easy-to-use web application based on R-Shiny, designed to facilitate flexible and rapid single sample annotation of transcriptional profiles from cancer patient samples in laboratories. It provides information on the molecular makeup of samples, as well as analysis of prognosis, druggability, and discovery of new information.

BMC BIOINFORMATICS (2022)

Article Gastroenterology & Hepatology

Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer

Shania M. Corry, Amy M. B. McCorry, Tamsin R. M. Lannagan, Niamh A. Leonard, Natalie C. Fisher, Ryan M. Byrne, Petros Tsantoulis, Xabier Cortes-Lavaud, Raheleh Amirkhah, Keara L. Redmond, Aoife J. McCooey, Sudhir B. Malla, Emily Rogan, Svetlana Sakhnevych, Michael A. Gillespie, Mark White, Susan D. Richman, Rene-Filip Jackstadt, Andrew D. Campbell, Sarah Maguire, Simon S. McDade, Daniel B. Longley, Maurice B. Loughrey, Helen G. Coleman, Emma M. Kerr, Sabine Tejpar, Timothy Maughan, Simon J. Leedham, Donna M. Small, Aideen E. Ryan, Owen J. Sansom, Mark Lawler, Philip D. Dunne

Summary: This study identifies and validates a HiFi-specific prognostic signature (HPS) based on STAT1-related signaling in the stroma-rich subtype of colon cancer. The HPS is associated with immune cell and antigen processing in stroma-rich colon cancer and treatment with the TLR3 agonist poly(I:C) can enhance the HPS signaling and reduce liver metastases.
Article Oncology

ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer Network

Vivek Kumar Singh, Md Mostafa Kamal Sarker, Yasmine Makhlouf, Stephanie G. Craig, Matthew P. Humphries, Maurice B. Loughrey, Jacqueline A. James, Manuel Salto-Tellez, Paul O'Reilly, Perry Maxwell

Summary: In this study, a lightweight deep learning model called ICOSeg is proposed to accurately segment the immune-checkpoint biomarker ICOS protein in colon cancer immunohistochemistry slide patches. The proposed model utilizes a convolutional neural network and transformer to extract relevant features from immunohistochemistry images and performs segmentation using an encoder and decoder sub-network. Experimental results show that ICOSeg achieves better segmentation results compared to existing methods with a reduction in parameters.

CANCERS (2022)

Article Oncology

Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis

Silvana Debernardi, Oleg Blyuss, Daria Rycyk, Kirtiman Srivastava, Christie Y. Jeon, Hui Cai, Qiuyin Cai, Xiao-Ou Shu, Tatjana Crnogorac-Jurcevic

Summary: This study assessed the predictive performance of a urine biomarker panel for early detection of pancreatic ductal adenocarcinoma (PDAC), and found that the combination with plasma CA19-9 could effectively detect PDAC up to 2 years prior to diagnosis.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Oncology

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer

Hajrah Khawaja, Rebecca Briggs, Cheryl H. Latimer, Mustasin Rassel, Dary Griffin, Lyndsey Hanson, Alberto Bardelli, Frederica Di Nicolantonio, Simon S. McDade, Christopher J. Scott, Shauna Lambe, Manisha Maurya, Andreas U. Lindner, Jochen H. M. Prehn, Jose Sousa, Chris Winnington, Melissa J. LaBonte, Sarah Ross, Sandra Van Schaeybroeck

Summary: Novel covalent inhibitors of KRASG12C have shown limited response rates in patients with KRASG12C-mutant colorectal cancer. In this study, researchers found that the combination of AZ'1569 and a Bcl-xL inhibitor led to a dramatic and universal apoptosis, suggesting a potential therapeutic strategy for patients with KRAS G12C-mutant colorectal cancer.

MOLECULAR CANCER THERAPEUTICS (2023)

Article Pathology

Technical note on the exploration of COVID-19 in autopsy material

Matthew Phillip Humphries, Victoria Bingham, Fatima Abdullah Sidi, Stephanie Craig, Beatrize Lara, Hesham El-daly, Nicole O'Doherty, Perry Maxwell, Claire Lewis, Stephen McQuaid, James Lyness, Jacqueline James, David R. J. Snead, Manuel Salto-Tellez

Summary: In this study, a validated protocol using multiplex immunofluorescence (mIF) was described for the exploration of the molecular physiopathology of SARS-CoV-2 pulmonary disease. Validated assays originally developed for the detection of SARS-CoV-2 in tissues were applied to map the adaptive immune response at protein and mRNA levels. The mIF panels showed robust, reliable, and quantifiable performance in detecting topographic variations in inflammation related to pathological processes in formalin-fixed, paraffin-embedded pneumonia material.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Cell Biology

Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D cancer cells

Ivana Steiner, Teresita del N. J. Flores-Tellez, Renaud Mevel, Amin Ali, Pengbo Wang, Pieta Schofield, Caron Behan, Nicholas Forsythe, Garry Ashton, Catherine Taylor, Ian G. Mills, Pedro Oliveira, Simon S. McDade, Dietmar M. Zaiss, Ananya Choudhury, Georges Lacaud, Esther Baena

Summary: Conditional deletion of PTEN gene in prostate cells leads to an increase in LY6D+ progenitor cells, resulting in the formation of castration-resistant prostate cancer with unmet clinical need. LY6D+ tumor cells are enriched in high-grade and androgen-resistant prostate cancer, providing clinical evidence for their contribution to advanced disease. Interfering with the MAPK signaling pathway can prevent the progression of castration-resistant prostate cancer.

CELL REPORTS (2023)

Article Oncology

Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an 'Immune Cold' Phenotype Associated with Poor Survival

Ross J. J. Porter, Graeme I. I. Murray, Sandra Hapca, Andrew Hay, Stephanie G. G. Craig, Matthew P. P. Humphries, Jacqueline A. A. James, Manuel Salto-Tellez, Daniel P. P. Brice, Susan H. H. Berry, Mairi H. H. McLean

Summary: This study investigates the role of HMGB1 in colorectal cancer and its association with tumor progression, lymph node metastases, and the immune microenvironment. Strong cytoplasmic HMGB1 expression is linked to an 'immune cold' tumor microenvironment and poor survival. HMGB1 may represent a new treatment target for colorectal cancer.

CANCERS (2023)

Article Cell Biology

Investigating the suitability of in vitro cell lines as models for the major subtypes of epithelial ovarian cancer

Aideen McCabe, Oza Zaheed, Simon Samuel McDade, Kellie Dean

Summary: Epithelial ovarian cancer (EOC) is a highly heterogeneous disease with five major histological subtypes. Cell line models that accurately represent these subtypes are essential for pre-clinical EOC research. This study aimed to generate a reference dataset of cell lines representative of the major EOC subtypes and identified lines with high molecular similarity to primary tumors. The findings highlight the importance of selecting suitable cell line models to maximize the clinical relevance of experiments.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer

K. Srivastava, K. E. Lines, D. Jach, T. Crnogorac-Jurcevic

Summary: Loss of S100PBP leads to oncogenic transformation of pancreatic cells, and the expression levels of S100P and S100PBP are closely associated with the prognosis of pancreatic cancer patients.

ONCOGENE (2023)

Article Multidisciplinary Sciences

Exploring the immune microenvironment in small bowel adenocarcinoma using digital image analysis

Fatima Abdullahi G. Sidi, Victoria C. Bingham, Stephen A. McQuaid, Stephanie P. Craig, Richard Turkington, Jacqueline James, Matthew Humphries, Manuel Salto-Tellez

Summary: This study analyzed the expression of immune cells and immune checkpoint biomarkers in a cohort of small bowel adenocarcinoma patients and assessed their impact on survival outcomes. The results showed that high expressions of CD3, CD4, IDO1, and ICOS were significantly associated with progression-free survival, while high PD-L1 expression in tumor cells was significantly associated with overall survival. These findings provide valuable insights for the immunotherapeutic management of small bowel adenocarcinoma patients.

PLOS ONE (2023)

Article Oncology

Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure

Laura Botta, Tomohiro Matsuda, Hadrien Charvat, Chun-Ju Chiang, Wen-Chung Lee, Anna Jacoba van Gestel, Frank Martin, Gijs Geleijnse, Matteo Cellamare, Simone Bonfarnuzzo, Rafael Marcos-Gragera, Marcela Guevara, Mohsen Mousavi, Stephanie Craig, Jessica Rodrigues, Jordi Rubio-Casadevall, Lisa Licitra, Stefano Cavalieri, Carlo Resteghini, Gemma Gatta, Annalisa Trama, RARECAREnet Working Grpo

Summary: Survival of head and neck cancers differs between Europe and Asia, with Europe having lower survival rates. Differences in cancer subsites, histology distribution, and survival were observed between the regions. The variations in survival could be attributed to different factors such as diagnosis period, advanced stage at diagnosis, or availability/access to treatment. The lack of stage and treatment information in cancer registries hinders further exploration of the reasons for survival differences. Federated learning has been proven as a feasible approach for data analysis that addresses the challenges of data sharing, emphasizing the need for collaborative studies involving relevant prognostic factors.

FRONTIERS IN ONCOLOGY (2023)

No Data Available